Cannabis Stock Prediction Tracker

The significant 12.42% decline today suggests continued selling pressure, while the absence of recent revenue data indicates potential operational challenges or reporting issues that typically concern investors. The extremely low price point of $0.04 and small market cap of $6.5M suggest the stock may face additional downside pressure as it approaches potential delisting thresholds, with limited institutional support likely at these levels.

The $0.00 price point with an 11.82% decline suggests ITHUF may be experiencing severe distress or delisting issues, while the lack of available financial metrics (revenue, margins) indicates potential operational challenges or reporting problems. Given the extremely low market cap of $26.1M for an MSO and absence of fundamental data, there appears to be a higher probability of continued downward pressure over the next 30 days.

The significant 11.03% decline today suggests strong selling pressure and negative momentum that is likely to persist in the near term. Despite strong gross margins of 94.9%, the extremely low market cap relative to TTM revenue of $173.7M indicates severe market skepticism about the company's prospects, and cannabis ancillary stocks have faced ongoing headwinds from regulatory uncertainty and market consolidation pressures.

The significant 10.1% decline today combined with the lack of available revenue data suggests potential fundamental challenges at Indiva. The extremely low share price of $0.02 and small market cap of $4.1M indicate the company may be facing liquidity or operational difficulties, which typically create continued downward pressure in the near term.

The significant 8.7% decline today suggests negative momentum that may persist in the near term, particularly given the absence of available fundamental metrics to assess underlying business health. MSO stocks have generally faced headwinds from regulatory uncertainty and capital access challenges, which likely continue to pressure valuations. Without visible revenue or margin data to indicate operational strength, technical momentum appears likely to drive continued downside pressure over the 30-day timeframe.

The 5.02% decline today suggests continued negative momentum in an already challenging cannabis sector environment. With limited financial fundamentals available and the ETF's small $9.5M market cap indicating potential liquidity constraints, there appears to be a higher probability of further downward pressure over the next 30 days.

The combination of an extremely low share price at $0.02, minimal market cap of $1.9M, and lack of available financial data suggests AYRWF is likely experiencing severe distress or potential delisting concerns. The 8.57% decline today indicates continued negative momentum, and MSO stocks have generally faced headwinds from regulatory uncertainty and capital market challenges. Without revenue data or clear operational metrics, there appears to be limited fundamental support for a near-term recovery.

The 5.05% decline today likely reflects continued pressure on cannabis sector ETFs amid ongoing regulatory uncertainty and challenging market conditions for cannabis equities. Given CNBS's relatively small market cap of $84.1M and the sector's persistent headwinds including limited institutional adoption and banking restrictions, there appears to be a higher probability of continued downward momentum over the next 30 days. The absence of revenue data suggests this ETF may be tracking smaller, less established cannabis companies that tend to be more volatile during market stress periods.

The combination of today's 5% decline, an extremely low market cap of $0.3M suggesting severe investor skepticism, and the broader biotech cannabis sector facing regulatory uncertainties and funding challenges creates a probabilistically bearish outlook. While the company maintains a reasonable gross margin of 41.4% and $15.7M in revenue, the market cap appears disconnected from fundamentals, indicating potential continued downward pressure over the next 30 days.

The lack of available revenue data suggests ETST may not be operationally active or transparent with financial reporting, which creates significant uncertainty for investors. Today's 5.17% decline combined with the extremely low share price of $0.11 indicates potential liquidity issues and limited institutional interest. Without clear revenue streams or growth metrics in a competitive cannabis market, the probability favors continued downward pressure over the next 30 days.

The 5.09% decline today suggests negative momentum, and the lack of available TTM revenue data indicates either minimal operations or reporting issues that typically concern investors. Cannabis sector fundamentals remain challenging with oversupply pressures and regulatory uncertainties, which likely creates continued downward pressure on smaller LPs like Cannara Biotech over the next 30 days.

While PLNHF shows positive momentum with today's 5.21% gain, the lack of available financial data including revenue and margin metrics suggests potential transparency or reporting issues that could concern investors. The cannabis MSO sector continues to face headwinds from regulatory uncertainty and capital constraints, which may limit sustained price appreciation despite short-term momentum.

The strong 7.01% gain today suggests positive momentum that could persist given Green Thumb's established market position as a leading MSO with operations across multiple states. However, the lack of available financial data creates uncertainty, and cannabis sector volatility remains elevated due to ongoing regulatory and market dynamics that could influence near-term performance.

While DBCCF shows positive momentum with today's 7.2% gain, the lack of available revenue data suggests potential financial reporting issues or very limited operations for a company with a $36M market cap. The Canadian cannabis sector continues to face headwinds including oversupply, pricing pressure, and regulatory challenges that typically weigh on smaller licensed producers without established revenue streams.

Despite today's 8.14% gain, MRMD appears fundamentally challenged with unavailable financial metrics suggesting potential reporting issues or very weak performance. The extremely low share price of $0.08 and small market cap of $32.3M indicate significant distress, while cannabis MSOs continue facing sector-wide pressures from regulatory uncertainty, banking limitations, and competitive dynamics that likely outweigh short-term momentum.

While BUDZ experienced a significant 9.83% gain today, the extremely low share price of $0.03 and tiny $3.8M market cap suggest high volatility and potential delisting risk. The absence of reported TTM revenue, revenue growth, and gross margin data indicates likely operational challenges or minimal business activity, which typically leads to continued downward pressure despite short-term momentum.

While TGIFF experienced a 10.4% gain today, the extremely low share price of $0.01 and minimal market cap of $2.6M suggest significant financial distress. The absence of revenue data indicates potential operational challenges or business suspension, which typically outweighs short-term momentum in penny stocks. The probability of decline appears higher given the lack of fundamental financial metrics to support sustained upward movement.

The 10.51% gain appears unsustainable given the absence of available revenue data and extremely low market cap of $4.4M, suggesting high volatility and speculative trading rather than fundamental strength. The CBD sector continues to face regulatory uncertainty and competitive pressures, while the lack of financial metrics indicates potential operational challenges that likely outweigh today's momentum over a 30-day period.

The absence of reportable TTM revenue and fundamental financial metrics suggests CANN may be a distressed or pre-revenue entity with extremely limited market capitalization. While the 14.29% daily gain indicates short-term momentum, the lack of operational fundamentals and minuscule market cap of $3.5M likely indicates high volatility and potential mean reversion. Cannabis sector volatility combined with apparent operational challenges suggests a higher probability of decline over the 30-day horizon.

Despite today's 16.39% gain, CBDNF appears to lack fundamental revenue generation with N/A TTM revenue and extremely low market cap of $1.8M, suggesting this may be a speculative microcap with limited operational substance. The CBD sector continues to face regulatory headwinds and oversupply issues, while the absence of financial metrics indicates potential business model challenges that likely outweigh short-term momentum.

While BBRRF experienced significant momentum with a 19.2% gain today, the lack of available revenue data and extremely low share price of $0.01 suggests high volatility and potential execution challenges. The cannabis sector has faced continued headwinds internationally, and micro-cap stocks with minimal financial transparency typically struggle to maintain momentum beyond short-term speculative moves.

While today's 24.48% gain indicates short-term momentum, the extremely low market cap of $1.1M and lack of revenue data suggests this is likely a speculative micro-cap with high volatility risk. The absence of fundamental financial metrics and the cannabis sector's continued challenges with profitability and regulatory pressures indicate a higher probability of price decline as momentum fades over the 30-day period.

Despite the 38.1% gain today, FNNZF appears to be a distressed microcap stock with a $0.5M market cap and no reported revenue, suggesting fundamental weakness. The extreme price volatility and lack of financial metrics indicate high speculative risk, with a probability that today's momentum is unsustainable over a 30-day period.

The extreme 111% daily gain from a $0.00 price base with minimal market cap suggests potential penny stock volatility or data anomalies rather than fundamental strength. The absence of revenue data and extremely small market capitalization indicate high speculative risk, with such dramatic price movements typically followed by significant retracements in micro-cap cannabis stocks.

Despite today's significant 24.5% gain, LFSWF appears to lack fundamental revenue generation with N/A TTM revenue, suggesting potential speculative trading rather than business fundamentals driving the price movement. The extremely low market cap of $1.1M and penny stock price of $0.03 indicate high volatility risk, where sharp gains are often followed by corrections in the absence of strong operational performance.

The 38.1% single-day gain appears unsustainable given the extremely low market cap of $0.5M and lack of meaningful revenue metrics, suggesting potential price manipulation or low-volume volatility typical of penny stocks. The absence of fundamental revenue data combined with the minimal market capitalization indicates high probability of price reversion within 30 days as speculative momentum likely dissipates.

The extreme 111% single-day gain combined with a $0.1M market cap and lack of financial data suggests this appears to be a penny stock experiencing speculative trading rather than fundamental value creation. Such dramatic price movements in micro-cap cannabis stocks typically indicate unsustainable momentum that tends to reverse as speculative interest wanes and profit-taking occurs.

The 24.5% single-day gain appears unsustainable given the extremely small market cap of $1.1M and absence of revenue data, suggesting this may be a speculative pump rather than fundamental improvement. The cannabis sector continues facing headwinds with oversupply issues and regulatory uncertainties, while micro-cap stocks like LFSWF typically experience high volatility with mean reversion tendencies following sharp moves.

While the 38.1% gain indicates strong short-term momentum, the extremely low market cap of $0.5M and lack of available revenue data suggest significant fundamental weaknesses. The absence of financial metrics combined with the micro-cap status indicates high volatility and elevated risk of price decline as initial momentum fades.

The extreme 111% daily gain from a $0.00 price point with negligible market cap and no revenue data suggests potential penny stock manipulation or extreme volatility rather than fundamental value creation. Such dramatic price movements in micro-cap cannabis stocks with absent financial metrics typically indicate unsustainable speculative activity that tends to reverse within 30 days as momentum fades.

The 36% single-day decline combined with extremely low market cap of $0.1M and absence of revenue data suggests severe fundamental distress or potential delisting risk. The lack of financial metrics indicates either very early-stage operations or significant operational challenges, making recovery within 30 days unlikely given current cannabis sector headwinds.

The severe 26.4% single-day decline suggests significant negative momentum, likely reflecting fundamental deterioration or adverse news that could continue pressuring the stock. With no reported revenue and an extremely low market cap of $7.4M, PCLOF appears to be in financial distress with limited operational visibility, making recovery within 30 days statistically unlikely. The combination of technical breakdown and apparent fundamental weakness creates a high probability of continued downward pressure in the near term.

The significant 13% decline today indicates strong negative momentum, and the lack of available revenue data suggests potential operational challenges or limited transparency that typically concern investors. Given the small market cap of $45.7M and the volatile nature of ancillary cannabis stocks, the probability of continued downward pressure appears elevated in the near term as investor sentiment remains fragile in this sector.

The substantial 12.4% decline today combined with the extremely low share price of $0.04 and minimal market cap suggests significant fundamental challenges. The absence of reportable TTM revenue data indicates potential operational difficulties or minimal business activity, which typically correlates with continued downward price pressure in small-cap cannabis stocks over a 30-day horizon.

The combination of today's significant 5.83% decline, extremely low market capitalization of $1.4M suggesting distressed status, and lack of available revenue data indicating potential operational challenges creates substantial downward momentum. The cannabis sector continues facing headwinds from regulatory uncertainty and capital constraints, which particularly impacts micro-cap companies like IMCC that may struggle with liquidity and operational sustainability.

The complete absence of financial data including TTM revenue and the $0.00 price point suggests ITHUF may be delisted or in severe financial distress. The 11.82% decline combined with extremely low market cap of $26.1M indicates ongoing liquidity issues and potential bankruptcy proceedings that typically continue deteriorating over 30-day periods.

The significant 11.03% decline today suggests negative momentum that may persist given MAPS' challenging fundamentals including a market cap of only $42M against $173.7M in revenue, indicating potential ongoing operational or market concerns. The cannabis ancillary sector continues to face headwinds from regulatory uncertainty and funding challenges, which could pressure the stock further over the next 30 days despite the company's strong gross margins.

The substantial 10.09% single-day decline combined with an extremely low share price of $0.02 and minimal market cap of $4.1M suggests significant fundamental challenges and potential delisting risk. The absence of available revenue data likely indicates operational difficulties or reporting issues that could persist over the next 30 days. These factors create considerable downward momentum that appears likely to continue in the near term given the precarious financial position.

The 8.7% decline suggests negative momentum that may persist given the lack of available financial data to assess fundamental strength. Without revenue metrics or growth indicators, there appears to be limited catalysts to drive recovery in the near term, while the broader MSO sector continues facing headwinds from regulatory uncertainty and capital constraints.

The extremely low price of $0.02 combined with an exceptionally small market cap of $1.9M and unavailable financial metrics suggests AYRWF is likely experiencing severe distress or potential delisting concerns. The 8.6% decline today indicates continued selling pressure, and without visible revenue or operational data, there appears to be minimal fundamental support for near-term price recovery in a challenging cannabis sector environment.

The combination of today's 5.17% decline, extremely low share price at $0.11, and lack of reported revenue data suggests significant fundamental weakness and potential liquidity issues. The absence of basic financial metrics like TTM revenue and growth rates indicates either operational challenges or transparency concerns that typically persist in the near term for micro-cap cannabis companies.

The lack of available TTM revenue and financial metrics suggests potential reporting issues or operational challenges, which creates uncertainty for investors. Today's 5.1% decline indicates negative momentum that could persist given the broader cannabis sector's ongoing volatility and regulatory headwinds. Without clear fundamental data to support valuation at current levels, the stock appears more likely to face continued downward pressure over the next 30 days.

Despite today's 5.01% gain, XXII faces significant challenges with an extremely low market cap of $0.4M suggesting potential liquidity issues and institutional skepticism. The biotech cannabis sector remains volatile with regulatory uncertainties, and while the 41.4% gross margin appears reasonable, the company's financial sustainability at this valuation level raises concerns about its ability to maintain current price levels over the next 30 days.

While today's 5.21% gain shows positive momentum, the absence of available financial data including revenue and growth metrics suggests potential transparency or performance issues that could concern investors. The cannabis sector remains highly volatile with regulatory uncertainties, and single-day gains often reverse in this market without strong fundamental support to sustain upward momentum.

The significant 7.01% gain suggests positive momentum that could persist given GTBIF's position as a major MSO with strong operational fundamentals. Cannabis sector sentiment appears to be improving, and Green Thumb's established retail footprint and operational efficiency historically support continued outperformance during positive market cycles.

While DBCCF experienced a 7.2% gain today, the absence of reported revenue data and fundamental metrics suggests potential financial distress or operational challenges common among smaller cannabis operators. The cannabis sector continues to face headwinds from oversupply, regulatory pressures, and capital constraints, which typically affect smaller players like Decibel more severely than established operators. Without visible revenue generation or clear operational improvements, the current momentum appears likely unsustainable over a 30-day period.

While MRMD experienced an 8.14% gain today, the absence of available TTM revenue data and key financial metrics suggests potential reporting issues or operational challenges that could create uncertainty. The extremely low stock price of $0.08 and small market cap of $32.3M indicates the company may be facing significant financial distress, which typically leads to continued volatility and downward pressure despite short-term momentum.

The lack of available revenue data and extremely low market cap suggests BUDZ may be distressed or non-operational, making the 9.83% daily gain likely unsustainable noise rather than fundamental improvement. Cannabis MSOs with established operations typically have accessible financial metrics, and the absence of TTM revenue data raises concerns about the company's current business status and ability to maintain recent price momentum.

The 10.42% gain appears likely to be temporary momentum given the extremely low share price of $0.01 and minimal market cap of $2.6M, which suggests potential financial distress. The absence of TTM revenue data and other fundamental metrics indicates possible operational challenges or lack of meaningful business activity, making sustained upward movement improbable over a 30-day period.

While today's 10.5% gain shows positive momentum, the lack of available revenue data and extremely small market cap of $4.4M suggests limited institutional interest and high volatility risk. The CBD sector faces ongoing regulatory uncertainty and market saturation pressures, which typically weigh more heavily on micro-cap stocks with unclear fundamentals over a 30-day horizon.